GENE ONLINE|News &
Opinion
Blog

Region
AstraZeneca Welcomes Neurofibromatosis And Asthma Treatment Approvals in Japan
2022-09-28
Sciwind Biosciences And SynerK Join Forces To Develop siRNA Therapeutics
2022-09-27
China’s Biocytogen And FineImmune Bring TCR-Mimic Antibodies And Cell Therapy Together
2022-09-16
Japan Approves AstraZeneca’s Complement Inhibitor For Rare Muscle Disorder
2022-08-26
BIOPLUS-INTERPHEX Korea 2022: The Now and Tomorrow of Korea’s Biotechnology Industry
2022-08-15
Sanofi Invests in Innovent to Gain Stronger Foothold in China
2022-08-05
CK Life Sciences and CK Hutchison Invest in Taiwanese Liquid Biopsy Candidate
2022-07-26
Everest, Calliditas Win First Approval for Rare Kidney Disease Drug in Europe
2022-07-18
Zhiyi Biotech Finishes Series B Funding With $45 Million For Live Biotherapeutics
2022-07-11
Brii Biosciences Begins Marketing COVID-19 Antibody Cocktail Therapy in China
2022-07-07
WuXi Biologics Adds Microbial Fermentation to CDMO Offering in Hangzhou
2022-07-05
Takeda Reveals Positive Data on Takhzyro at EAACI
2022-07-01
Innovent, Lilly’s PD-1 Inhibitor Approved to Treat Esophageal Cancer in China
2022-06-21
Shenzhen Joincare Plots $300 Million IPO On Swiss Exchange
2022-06-20
Organon Licenses Biosimilars From Shanghai’s Henlius For $103 Million
2022-06-14
1 2 3 34
LATEST
Biogen Concludes $900 Million Settlement Before Posting Positive Data From Alzheimer’s Trial
2022-09-28
Arsenal Biosciences Announced Another $70 million Collaboration, This Time With Genentech
2022-09-27
Sciwind Biosciences And SynerK Join Forces To Develop siRNA Therapeutics
2022-09-27
Acticor Enrolls First Patient in Phase 2/3 Stroke Treatment Study
2022-09-27
Daiichi Sankyo Wins Approval For Cancer Treatment in Japan
2022-09-26
Seagen Strikes Potential $650 million Deal with LAVA Therapeutics for Cancer Treatment
2022-09-26
Pfizer, Sangamo Re-Opens Enrolment For Hemophilia A Gene Therapy
2022-09-26
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!